Prevalence of Cytopenia and its Correlation with Immunosuppression in Naïve HIV-1 Infected Patients Initiating First-Line Antiretroviral Therapy: A Pilot Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Cytopenias serve as common indicators and crucial predictive tools for evaluating disease progression and therapeutic outcomes in individuals with human immunodeficiency virus (HIV) infection. This study aimed to assess the prevalence of cytopenias and their correlation with the level of immunosuppression in treatment-naive HIV-infected participants after initiating highly active combined antiretroviral drug therapy (cART24). Materials and Methods: This prospective study focused on evaluating cytopenia in 44 treatment-naive HIVinfected patients who consented to initiate cART and were consecutively enrolled. The research was conducted at the Nasara HIV Treatment & Care Centre of Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria, spanning from December 2016 to January 2018. Cytopenias, including anemia, leucopenia, lymphocytopenia, and thrombocytopenia, were defined and assessed according to World Health Organization guidelines. A combination of cross-sectional and longitudinal mixed-design two-step analysis was employed to validate our findings. Results: The median time from enrollment to cART initiation was 7 days, following the universal test and treat protocol. The prevalence of cytopenia was 75% at the baseline before treatment and increased to 84% after cART24 administration. There were no statistically significant differences in the median values of immuno-hematological parameters between baseline and after cART24 initiation (P >0.05). In terms of longitudinal assessment, the prevalence of anemia, leucopenia, lymphopenia, and thrombocytopenia at baseline were 66%, 23%, 0%, and 11%, respectively, and after cART24, the rates were 66%, 29%, 5%, and 20%. Notably, the prevalence of cytopenia correlated with declining CD4+ T cell counts. Among instances of unicytopenia, 58% exhibited isolated anemia, 6% had lone leucopenia, and 6% had solitary thrombocytopenia. Additionally, 27% demonstrated bi-cytopenia, and 3% exhibited pancytopenia. Interestingly, none of the study participants presented with lymphopenia. The most common combination was anemia and thrombocytopenia. Both longitudinal and cross-sectional analytical findings were consistent. Conclusion: In treatment-naive HIV-infected individuals, the prevalence of cytopenias, particularly anemia and thrombocytopenia, was substantial and correlated with the degree of immunosuppression as indicated by CD4+ T cell counts. These cytopenias persisted despite initiation of cART24, highlighting the complexity of hematological manifestations in HIV infection. Our study underscores the significant hematopathological impact of HIV and antiretroviral therapy, highlighting the necessity for preventive strategies to mitigate these adverse effects.
Abstract
Background: Cytopenias serve as common indicators and crucial predictive tools for evaluating disease progression and therapeutic outcomes in individuals with human immunodeficiency virus (HIV) infection. This study aimed to assess the prevalence of cytopenias and their correlation with the level of immunosuppression in treatment-naive HIV-infected participants after initiating highly active combined antiretroviral drug therapy (cART24). Materials and Methods: This prospective study focused on evaluating cytopenia in 44 treatment-naive HIVinfected patients who consented to initiate cART and were consecutively enrolled. The research was conducted at the Nasara HIV Treatment & Care Centre of Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria, spanning from December 2016 to January 2018. Cytopenias, including anemia, leucopenia, lymphocytopenia, and thrombocytopenia, were defined and assessed according to World Health Organization guidelines. A combination of cross-sectional and longitudinal mixed-design two-step analysis was employed to validate our findings. Results: The median time from enrollment to cART initiation was 7 days, following the universal test and treat protocol. The prevalence of cytopenia was 75% at the baseline before treatment and increased to 84% after cART24 administration. There were no statistically significant differences in the median values of immuno-hematological parameters between baseline and after cART24 initiation (P >0.05). In terms of longitudinal assessment, the prevalence of anemia, leucopenia, lymphopenia, and thrombocytopenia at baseline were 66%, 23%, 0%, and 11%, respectively, and after cART24, the rates were 66%, 29%, 5%, and 20%. Notably, the prevalence of cytopenia correlated with declining CD4+ T cell counts. Among instances of unicytopenia, 58% exhibited isolated anemia, 6% had lone leucopenia, and 6% had solitary thrombocytopenia. Additionally, 27% demonstrated bi-cytopenia, and 3% exhibited pancytopenia. Interestingly, none of the study participants presented with lymphopenia. The most common combination was anemia and thrombocytopenia. Both longitudinal and cross-sectional analytical findings were consistent. Conclusion: In treatment-naive HIV-infected individuals, the prevalence of cytopenias, particularly anemia and thrombocytopenia, was substantial and correlated with the degree of immunosuppression as indicated by CD4+ T cell counts. These cytopenias persisted despite initiation of cART24, highlighting the complexity of hematological manifestations in HIV infection. Our study underscores the significant hematopathological impact of HIV and antiretroviral therapy, highlighting the necessity for preventive strategies to mitigate these adverse effects.
참고문헌 (40)
- Greenblatt R, "Genetic and clinical predictors of CD4 lymphocyte recovery during suppressive antiretroviral therapy : whole exome sequencing and antiretroviral therapy response phenotypes", PLoS One, 14, pp.e0219201~ (2019)
- Mohamad WMW, "Immunological and haematological changes in HIV infectiontowards a functional cure", InTech
- Renelt S, "HIV-1 infection of long-lived hematopoietic precursors in vitro and in vivo", Cells, 11, pp.2968~ (2022)
- Tsukamoto T, "Hematopoietic stem", progenitor cells and the pathogenesis of HIV, Front Cell Infect Microbiol, pp.2020, 10[DOI]
- Alexaki A, "HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination", PLoS Pathog, 4, pp.e1000215~ (2008)
- Zhang J, "Hematopoietic stem and progenitor cells in HIV", AIDS and immune reconstitution, 2010, pp.20, 745~747
- Isgrò A, "Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy", AIDS Res Hum Retroviruses, 16, pp.1471~1479 (2000)
- Gibellini D, "Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages", World J Virol, 2, pp.91~101 (2013)
- Ako SE, "Hematological related disorders and transfusion of HIV patients on highly active antiretroviral therapy(HAART)in the South West Region of Cameroon : hematological monitory parameters for HIV followup", J HIV Retrovirus, 4, pp.5~ (2018)
- Lee CY, "Comparison of virological efficacy of DTG", ABC, F, pp.TAF regimens and discontinuation patterns in persons living with advanced HIV in the era of rapid ART : a retrospective multicenter cohort study, Infect Dis Ther[DOI]
- Redd AD, "Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa", Blood, 110, pp.3143~3149 (2007)
- Nazziwa J, "Characterisation of HIV-1 molecular epidemiology in Nigeria : origin, diversity, demography and geographic spread", Sci Rep, 10, pp.3468~ (2020)
- Sale A, "Prevalence of pancytopenia among human immuno-virus(HIV)sero-positive clients attending anti-retroviral therapy(ART)clinic in general hospital Kachia, Kaduna State", Niger Biomed Sci J, 15, pp.17~22 (2018)
- Akinbo FO, "Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy(HAART)in Benin city, Nigeria", J Res Health Sci, 12, pp.15~18 (2012)
- Adeiza MA, "Dolutegravir hypersensitivity reaction : the need for strengthening pharmacovigilance systems with optimization of antiretroviral therapy in HIV programs in resource-limited settings(case report)", PAMJ-CM, 8, pp.47~ (2022)
- Tigabu A, "Incidence and predictors of anemia among adults on HIV care at South Gondar Zone Public General Hospital Northwest Ethiopia, 2020; retrospective cohort study", PLoS One, 17, pp.e0259944~ (2022)
- Cao G, "Prevalence of anemia among people living with HIV : a systematic review and metaanalysis", EClinicalMedicine, 44, pp.101283~ (2022)
- Bisetegn H, "The prevalence of thrombocytopenia and leucopenia among people living with HIV", AIDS in Ethiopia : a systematic review and meta-analysis, 2021, pp.16, e0257630~
- Balogun T, "The pattern of haematological changes in the baseline blood cell counts and the CD4+ T lymphocyte levels among antiretroviral therapy naïve adult HIV positive patients in a Nigerian hospital", Open J Blood Dis, 10, pp.77~88 (2020)
- Duguma N, "Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, Southeast Ethiopia : a cross-sectional study", SAGE Open Med, 9, pp.20503121211020175~ (2021)
- Denue BA, "Prevalence of anemia and immunological markers in HIVinfected patients on highly active antiretroviral therapy in Northeastern Nigeria", Infect Dis(Auckl), 6, pp.25~33 (2013)
- Girum T, "The effect of"universal test and treat"program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment(ART)in low income settings of Gurage zone, South Ethiopia", AIDS Res Ther, 17, pp.19~ (2020)
- Gunda DW, "Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania : a cross-sectional study", Malawi Med J, 29, pp.43~52 (2017)
- Bhardwaj S, "Hematologic derangements in HIV", AIDS patients and their relationship with the CD4 counts : a cross-sectional study, 2020, pp.13, 756~763
- Balogun O, "Impact of viral load suppression on CD4 + T-cell count and BMI following combine antiretroviral therapy(cART)in HIV-1 infected individuals : preliminary findings in a resource poor setting", Anti-Infective Agents, 20, pp.e020622205560~ (2022)
- Balogun O, "Effects of anti-retroviral therapy on baseline serum interleukin-18 levels in HIV-I infected patients relative to viral suppression and CD4+ gain : a prospective pilot study", Biomedicine(Taipei), 13, pp.24~33 (2023)
- Wankah PN, "Profile of blood cell abnormalities among antiretroviral therapy naïve HIV patients attending the Yaounde University Teaching Hospital, Cameroon", BMC Hematol, 14, pp.15~ (2014)
- De Santis GC, "Hematological abnormalities in HIV-infected patients", Int J Infect Dis, 15, pp.e808~11 (2011)
- Fahey JL, "Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection", Clin Diagn Lab Immunol, 5, pp.597~603 (1998)
- Enawgaw B, "Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia : a comparative cross-sectional study", BMC Hematol, 14, pp.8~ (2014)
- Damtie S, "Hematological abnormalities of adult HIV-infected patients before and after initiation of highly active antiretroviral treatment at Debre Tabor Comprehensive Specialized Hospital, Northcentral Ethiopia : a cross-sectional study", HIV AIDS(Auckl), 13, pp.477~484 (2021)
- Jain V, "Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size", J Infect Dis, 208, pp.1202~1211 (2013)
- Fan L, "Prevalence and risk factors of cytopenia in HIV-infected patients before and after the initiation of HAART", BioMed Res Int, 2020, pp.3132589~ (2020)
- Al Mamun Bhuyan A, "Enhanced eryptosis following exposure to dolutegravir", Cell Physiol Biochem, 39, pp.639~650 (2016)
- Zhao Y, "Risk of immune reconstitution inflammatory syndrome with integrase inhibitors versus other classes of antiretrovirals : a systematic review and meta-analysis of randomized trials", J Acquir Immune Defic Syndr, 90, pp.232~239 (2022)
- Giovanetti M, "Molecular epidemiology of HIV-1 in African countries : a comprehensive overview", Pathogens, 9, pp.1072~ (2020)
- Omoregie R, "Prevalence of anaemia among HIV-infected patients in Benin City, Nigeria", Tanzan J Health Res, 11, pp.1~4 (2009)
- "Guidelines for HIV diagnosis and monitoring of antiretroviral therapy"[URL]
- Schreibman T, "Use of total lymphocyte count for monitoring response to antiretroviral therapy", Clin Infect Dis, 38, pp.257~262 (2004)
- Madzime M, "Interactions of HIV and antiretroviral therapy with neutrophils and platelets", Front Immunol, 12, pp.634386~ (2021)